DARC shuttles inflammatory chemokines across the blood–brain barrier during autoimmune central nervous system inflammation
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The Duffy antigen/receptor for chemokines, DARC, belongs to the family of atypical heptahelical chemokine receptors that do not couple to G proteins and therefore fail to transmit conventional intracellular signals. Here we show that during experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis, the expression of DARC is upregulated at the blood-brain barrier. These findings are corroborated by the presence of a significantly increased number of subcortical white matter microvessels staining positive for DARC in human multiple sclerosis brains as compared to control tissue. Using an in vitro blood-brain barrier model we demonstrated that endothelial DARC mediates the abluminal to luminal transport of inflammatory chemokines across the blood-brain barrier. An involvement of DARC in experimental autoimmune encephalomyelitis pathogenesis was confirmed by the observed ameliorated experimental autoimmune encephalomyelitis in Darc(-/-) C57BL/6 and SJL mice, as compared to wild-type control littermates. Experimental autoimmune encephalomyelitis studies in bone marrow chimeric Darc(-/-) and wild-type mice revealed that increased plasma levels of inflammatory chemokines in experimental autoimmune encephalomyelitis depended on the presence of erythrocyte DARC. However, fully developed experimental autoimmune encephalomyelitis required the expression of endothelial DARC. Taken together, our data show a role for erythrocyte DARC as a chemokine reservoir and that endothelial DARC contributes to the pathogenesis of experimental autoimmune encephalomyelitis by shuttling chemokines across the blood-brain barrier.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Capture, crawl, cross: the T cell code to breach the blood–brain barriers
Engelhardt, B., & Ransohoff, R. M. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.07.004 · Cited by 686 · cited 2×
“This is followed by LFA-1-ICAM1/2 mediated T cell polarization and T cell crawling on the blood–brain barrier against the direction of blood flow with the aim to find a site permissive for diapedesis across the blood–brain barrier (Engelhardt and Ransohoff, 2012).”
BackgroundSelf-citationIzikson, L., Klein, R. S., Charo, I. F., Weiner, H. L., & Luster, A. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1075 · Cited by 584 · cited 7×
“In fact it has been demonstrated that CCL2 can be transported from the abluminal to the luminal side of brain microvascular endothelial cells by a transcellular mechanism that at least in part involves binding of CCL2 to CCR2 and caveolae (Dzenko et al., 2001; Ge et al., 2008).”
BackgroundInfluentialCc Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune Encephalomyelitis
Fife, B. T., Huffnagle, G. B., Kuziel, W. A., & Karpus, W. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.6.899 · Cited by 511 · cited 7×
“In fact it has been demonstrated that CCL2 can be transported from the abluminal to the luminal side of brain microvascular endothelial cells by a transcellular mechanism that at least in part involves binding of CCL2 to CCR2 and caveolae (Dzenko et al., 2001; Ge et al., 2008).”
BackgroundInfluentialRansohoff, R. M., Hamilton, T. A., Tani, M., Stoler, M. H., Shick, H. E., Major, J. A., Estes, M. L., Thomas, D. M., & Tuohy, V. K. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.6.8472896 · Cited by 496
Steiner, O., Coisne, C., Cecchelli, R., Boscacci, R., Deutsch, U., Engelhardt, B., & Lyck, R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903732 · Cited by 293
Self-citationThe blood-brain barrier, chemokines and multiple sclerosis
Holman, D. W., Klein, R. S., & Ransohoff, R. M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.019 · Cited by 247 · cited 2×
“Interestingly, although expression of CCL2 and CCL5 can readily be detected in cultured brain endothelial cells in vitro (Holman et al., 2011), in multiple sclerosis lesions and in EAE, both chemokines are expressed rather by astrocytes or infiltrating immune cells (Ubogu et al., 2006).”
BackgroundPiccio, L., Rossi, B., Scarpini, E., Laudanna, C., Giagulli, C., Issekutz, A. C., Vestweber, D., Butcher, E. C., & Constantin, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.4.1940 · Cited by 245
McCandless, E. E., Piccio, L., Woerner, B. M., Schmidt, R. E., Rubin, J. B., Cross, A. H., & Klein, R. S. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070918 · Cited by 206 · cited 2×
“CXCL12 might therefore become luminally available during neuroinflammation and mediate T cell arrest to the inflamed blood–brain barrier in EAE and multiple sclerosis (McCandless et al., 2006, 2008; Moll et al., 2009).”
BackgroundEngelhardt, B., Laschinger, M., Schulz, M., Samulowitz, U., Vestweber, D., & Hoch, G. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4271 · Cited by 203 · cited 1×
“In vitro antigen-recall assays to test for antigen-specific proliferation of T cells was determined by measuring 3H-thymidine incorporation into the DNA of proliferating T cells as previously described (Engelhardt et al., 1998; Doring et al., 2007).”
MethodSelf-citationPfeiffer, F., Schäfer, J., Lyck, R., Makrides, V., Brunner, S., Schaeren-Wiemers, N., Deutsch, U., & Engelhardt, B. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0883-2 · Cited by 160 · cited 1×
“Immunofluorscence staining of mouse tissue sections and on pMBMECs (primary mouse brain microvascular endothelial cells) were performed as described previously (Pfeiffer et al., 2008, 2011; Steiner et al., 2011).”
MethodSelf-citation
Cited by
Erickson, M. A., & Banks, W. A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014647 · Cited by 378
Girbl, T., Lenn, T., Perez, L., Rolas, L., Barkaway, A., Thiriot, A., del Fresno, C., Lynam, E., Hub, E., Thelen, M., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.018 · Cited by 357
Self-citationMarchetti, L., & Engelhardt, B. (2020) · Vascular Biology · doi:10.1530/vb-19-0033 · Cited by 304
“In this context it is interesting to note that the atypical chemokine receptor 1 (ACKR1) is upregulated on the BBB during EAE and in MS (74).”
BackgroundPassing the Vascular Barrier: Endothelial Signaling Processes Controlling Extravasation
Wettschureck, N., Strilic, B., & Offermanns, S. (2019) · Physiological Reviews · doi:10.1152/physrev.00037.2018 · Cited by 286
(2016) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-63432-0.00003-7 · Cited by 202
Metadata
- Authors
- Minten, C., Alt, C., Gentner, M., Frei, E., Deutsch, U., Lyck, R., Schaeren-Wiemers, N., Rot, A., & Engelhardt, B.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-03-12
- Volume
- 137
- Issue
- 5
- Pages
- 1454-1469
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2141369179
- Cited by
- 87
- References
- 12
- FWCI
- 2.15
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: DARC shuttles inflammatory chemokines across the blood–brain barrier during autoimmune central nervous system inflammation. https://app.cochat.ai/papers/10.1093/brain/awu045
- The paper
- Minten, C., Alt, C., Gentner, M., Frei, E., Deutsch, U., Lyck, R., Schaeren-Wiemers, N., Rot, A., & Engelhardt, B. (2014). DARC shuttles inflammatory chemokines across the blood–brain barrier during autoimmune central nervous system inflammation. Brain. https://doi.org/10.1093/brain/awu045
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.